Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of cisatracurium vs succinylcholine in electroconvulsive therapy
IRCT20110425006280N14Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cisatracurium and succinylcholine in mental disorder (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: efficacy of muscle relaxation during ECT and safety profile. Started Jun 2023; status: completed.
02
Drugs
cisatracuriumsuccinylcholine
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20110425006280N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110425006280N14.